🧪
Active substance
recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus
✅ No active alerts
✅
All clear right now
No active EU-wide shortages or safety letters for this substance. National-level issues may still exist.
No EU-centralised brands tracked yet
recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus is commonly nationally-authorised rather than centrally via EMA. We currently only track centrally-authorised EU medicines and shortages. National-level data for this substance is on the roadmap.